NES

Nestin · P48681 · NES on Sugi Atlas →

0 patent compounds predicted against NES, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NES by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Irinotecan Liposomes for the Treatment of Neuroendocrine Carcinoma PHASE4NOT_YET_RECRUITING
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder PHASE4COMPLETED
Safety of Autologous MSC Infusion to Treat Epilepsy PHASE1/PHASE2COMPLETED
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation PHASE2COMPLETED
Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease PHASE1/PHASE2UNKNOWN
Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD). PHASE1/PHASE2UNKNOWN
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI PHASE1/PHASE2RECRUITING
Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke PHASE1/PHASE2UNKNOWN
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells PHASE1/PHASE2COMPLETED
SVF (Adipose Tissue Derived MSC) Based Therapy for CKD. PHASE1/PHASE2UNKNOWN
A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells EARLY_PHASE1UNKNOWN
Structural Chromosome Rearrangements and Brain Disorders nanENROLLING_BY_INVITATION
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) nanRECRUITING
Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation nanCOMPLETED
Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury nanNOT_YET_RECRUITING
The Cognitive-Behavioral Dysfunctions and the Potential of Neuroplasticity in Brain Tumors Patients During Radiotherapy nanUNKNOWN
Neurocognitive Function After Prophylactic Cranial Irradiation & Hippocampal Sparing in LD SCLC Patients - a Pilot Study nanUNKNOWN
Role of Brain Specific Biomarkers in Hydrocephalus nanCOMPLETED
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN) nanRECRUITING
Stem Cells in NF1 Patients With Tumors of the Central Nervous System nanWITHDRAWN
Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem nanUNKNOWN
Role of LncRNA H19 in The Regulation of IGF-1R Expression nanCOMPLETED
Clinicolaboratory Predictors of Outcome in Children With Encephalitis nanNOT_YET_RECRUITING
Treatment Outcomes in PASC Patients With Neurocognitive Impairment nanCOMPLETED
Single-cell Sequencing and Establishment of Models in Neuroendocrine Neoplasm nanUNKNOWN
Genetic Susceptibility Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA]) nanCOMPLETED
S100β and Neuron Specific Enolase Levels in Liver Transplantation nanCOMPLETED
Hippocampal Neurogenesis in Human Subjects nanCOMPLETED
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NES binder may also engage these)

ProteinNameSimilarity
Q6P5H2 1.000 Q6P5H2 →
P21263 0.999 P21263 →
Q5TM66 0.990 Q5TM66 →
Q8N3D4 0.988 Q8N3D4 →
Q8N1P7 0.988 Q8N1P7 →
Q767M0 0.987 Q767M0 →
MDC1 Mediator of DNA damage checkpoint protein 1 0.986 landscape →
Q7YR40 0.986 Q7YR40 →
Q9UDV7 0.985 Q9UDV7 →
Q767L8 0.985 Q767L8 →
P0C671 0.985 P0C671 →
Q6NYC8 0.985 Q6NYC8 →
Q5TM68 0.985 Q5TM68 →
Q99MS7 0.985 Q99MS7 →
A4FU49 0.984 A4FU49 →
Q8BQ30 0.984 Q8BQ30 →
A2TJV2 0.984 A2TJV2 →
Q96M43 0.983 Q96M43 →
Q9Z1Q1 0.983 Q9Z1Q1 →
Q5VWK0 0.983 Q5VWK0 →
Q7Z6P3 0.983 Q7Z6P3 →
Q4R729 0.982 Q4R729 →
Q96L96 0.982 Q96L96 →
P58871 0.981 P58871 →
Q3UNH4 0.981 Q3UNH4 →
Q9H7P9 0.981 Q9H7P9 →
A6NDB9 0.981 A6NDB9 →
Q96IT1 0.981 Q96IT1 →
Q6ZRC1 0.980 Q6ZRC1 →
Q9Y6A5 0.980 Q9Y6A5 →